FADROZOLE HYDROCHLORIDE HEMIHYDRATE

Possibly Marketed Outside US

Details

Stereochemistry	RACEMIC
Molecular Formula	2C14H13N3.2ClH.H2O
Molecular Weight	537.483
Optical Activity	( + / - )
Defined Stereocenters	0 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of FADROZOLE HYDROCHLORIDE HEMIHYDRATE

SMILES

O.Cl.Cl.N#CC1=CC=C(C=C1)C2CCCC3=CN=CN23.N#CC4=CC=C(C=C4)C5CCCC6=CN=CN56

InChI

InChIKey=RBNOZCGLHXZRLF-UHFFFAOYSA-N

InChI=1S/2C14H13N3.2ClH.H2O/c2*15-8-11-4-6-12(7-5-11)14-3-1-2-13-9-16-10-17(13)14;;;/h2*4-7,9-10,14H,1-3H2;2*1H;1H2

HIDE SMILES / InChI

Description

Fadrozole (CGS 16949A) is a tetrahydroimidazole-pyridine derivative is a non-steroidal inhibitor of aromatase. In the third phase of clinical trials it was shown, that this drug has good therapeutic effect as a second-line treatment in postmenopausal women with metastatic breast cancer.

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Cytochrome P450 19A1 39	Inhibitor 8,504

Conditions

Condition	Modality	Targets	Highest Phase	Product
Breast cancer 432	Primary		Phase III 665	Unknown

C_max

Value	Dose	Analyte	Population
32.3 ng/mL	12 mg single, oral	FADROZOLE plasma	Homo sapiens
27.4 ng/mL	12 mg single, oral	FADROZOLE plasma	Homo sapiens
1.5 ng/mL	0.3 mg 2 times / day multiple, oral	FADROZOLE plasma	Homo sapiens
1.5 ng/mL	1 mg 2 times / day multiple, oral	FADROZOLE plasma	Homo sapiens
1.5 ng/mL	2 mg 2 times / day multiple, oral	FADROZOLE plasma	Homo sapiens

AUC

Value	Dose	Analyte	Population
336 ng × h/mL	12 mg single, oral	FADROZOLE plasma	Homo sapiens
306 ng × h/mL	12 mg single, oral	FADROZOLE plasma	Homo sapiens
10.7 ng × h/mL	0.3 mg 2 times / day multiple, oral	FADROZOLE plasma	Homo sapiens
10.5 ng × h/mL	1 mg 2 times / day multiple, oral	FADROZOLE plasma	Homo sapiens
10.7 ng × h/mL	2 mg 2 times / day multiple, oral	FADROZOLE plasma	Homo sapiens

T_1/2

Value	Dose	Co-administered	Analyte	Population
1.8 h	12 mg single, oral		FADROZOLE plasma	Homo sapiens
2.5 h	12 mg single, oral		FADROZOLE plasma	Homo sapiens

Doses

Show entries

Dose	Population	Adverse events
12 mg single, oral Highest studied dose	healthy, ADULT
2 mg 2 times / day multiple, oral Highest studied dose	unhealthy, ADULT	Disc. AE: Depression, Lethargy...
1 mg 2 times / day multiple, oral Studied dose	unhealthy, ADULT	Disc. AE: Weakness, Dizziness...

Showing 1 to 3 of 3 entries

Previous1Next

AEs

Show entries

AE	Significance	Dose	Population
Depression	grade 3, 3.6% Disc. AE	2 mg 2 times / day multiple, oral Highest studied dose	unhealthy, ADULT
Lethargy	grade 3, 3.6% Disc. AE	2 mg 2 times / day multiple, oral Highest studied dose	unhealthy, ADULT
Dizziness	0.95% Disc. AE	1 mg 2 times / day multiple, oral Studied dose	unhealthy, ADULT
Weakness	0.95% Disc. AE	1 mg 2 times / day multiple, oral Studied dose	unhealthy, ADULT

Showing 1 to 4 of 4 entries

Previous1Next

PubMed

Show entries

Title	Date	PubMed
Relationship of serum HER-2/neu and serum CA 15-3 in patients with metastatic breast cancer.	2002 Aug	12142389
Aromatase inhibitors block natural sex change and induce male function in the protandrous black porgy, Acanthopagrus schlegeli Bleeker: possible mechanism of natural sex change.	2002 Jun	12021057
Elevated serum Her-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer.	2002 Mar 15	11896093
Evaluation of a 15-day screening assay using intact male rats for identifying steroid biosynthesis inhibitors and thyroid modulators.	2002 Sep	12215662
Induction of XY sex reversal by estrogen involves altered gene expression in a teleost, tilapia.	2003	14684997

Showing 1 to 5 of 14 entries

Previous1 2 3Next

Patents

Sample Use Guides

In Vivo Use Guide

0.5, 1.0 or 2.0 mg orally b.d.

Route of Administration: Oral

In Vitro Use Guide

CGS-16949A (fadrozole) blocked aromatase by 50% in human breast cancer homogenates, live breast cancer cells, human placental microsomes and porcine ovarian microsomes at concentrations of 0.008 to 0.02 microM

Show entries

Name

Type

Language

FADROZOLE HYDROCHLORIDE HYDRATE

Preferred Name

English

FADROZOLE HYDROCHLORIDE HEMIHYDRATE

Common Name

English

BENZONITRILE, 4-(5,6,7,8-TETRAHYDROIMIDAZO(1,5-A)PYRIDIN-5-YL)-, HYDROCHLORIDE, HYDRATE (2:2:1)

Systematic Name

English

BENZONITRILE, 4-(5,6,7,8-TETRAHYDROIMIDAZO(1,5-A)PYRIDIN-5-YL)-, MONOHYDROCHLORIDE, HYDRATE (2:1)

Common Name

English

FADROZOLE HYDROCHLORIDE HYDRATE [JAN]

Common Name

English

Showing 1 to 5 of 6 entries

Previous1 2Next

Show entries

Code System

Code

Type

Description

PUBCHEM

11954367

PRIMARY

SMS_ID

100000127581

PRIMARY

FDA UNII

O5207G4XQ9

PRIMARY

EVMPD

SUB33655

PRIMARY

CAS

176702-70-8

PRIMARY

Showing 1 to 5 of 5 entries

Previous1Next

ACTIVE MOIETY


					H3988M64PU

FADROZOLE

PARENT (SALT/SOLVATE)


					H0Q44H4ECQ

FADROZOLE HYDROCHLORIDE

SUBSTANCE RECORD


					O5207G4XQ9

FADROZOLE HYDROCHLORIDE HEMIHYDRATE

SMILES

InChI

Originator

Approval Year

Targets

Conditions

Cmax

AUC

T1/2

Doses

AEs

PubMed

Patents

Sample Use Guides

C_max

T_1/2